-
PenRad is Your Most Trusted Mammography Analytics Partner. PenRad is Your Most Trusted Business Partner.
[vc_row][vc_column][vc_column_text css=”.vc_custom_1650401649661{margin-bottom: 0px !important;}”]While it is well established PenRad provides the most trusted products available to manage the quality, workflow, analytics, and patient engagement in women’s imaging, did you know PenRad is also looking out for the health of its client’s business? Managing the health of a patient is the primary goal of any physicians…
-
Genetic Testing for Hereditary Cancers in Women’s Imaging. Now is the Time.
[vc_row][vc_column][vc_column_text css=”.vc_custom_1641313634134{margin-bottom: 0px !important;}”]In the 1990’s when BRCA1 and BRCA2 were found to be associated with an increased risk of developing breast cancer, getting patients tested for these genetic mutations was difficult. The thought of widespread testing of patients represented a nearly insurmountable challenge for a multitude of reasons. Since that time genetic testing has…
-
Novarad and PenRad partner to provide further diagnostic tracking functionality to healthcare providers
Healthcare IT company Novarad to offer PenRad’s PenLung automated tracking and reporting system for lung screening and lung cancer as part of its diagnostic suite SALT LAKE CITY – Novarad, a leading provider of medical software, announced today that it has expanded its strategic partnership with mammography analytics company, PenRad, Inc. PenRad’s automated tracking and…